EUVIMED · CrossrefZeitschrift
Value in Health
ISSN 1098-3015 · Elsevier BV
Neueste Artikel
EQ-5D-5L in Post-COVID-19 Condition
Official Digital Health Technology Assessment Guidelines: An International Comparative Review and Analysis
The Costs, Cost-Effectiveness, and Methods for Evaluating Clinical Registries: A Systematic Scoping Review
Developing Best Practice for Analyzing Individual Patient Utility Data in Health Technology Assessment: A Modified Delphi Study
Author Reply
Discounting Shortfall, Increasing Barriers: Pragmatic Objections to Discounting Shortfall in the NICE Severity Modifier
Stakeholder Perspectives on Potential Open-Label Bias in Patient-Reported Outcome Results From Cancer Clinical Trials: Evidence From the IMPROvE Project
Psychometric Properties of the Experimental and Modified EQ-HWB and EQ-HWB-9 in Patients with Anxiety and/or Depression in China
Physician-Led Switching From Reference Biologics to Biosimilars: What Is the Effect on Selected Health-Related Outcomes and Costs for Patients With Inflammatory Bowel Disease in Germany?
A Competency Framework for Health Technology Assessment Expertise: Results From a Delphi Study
Are Preference-Weighted Cancer-Specific Measures More Sensitive Than Generic Measures? A Comparison of EQ-5D-5L, SF-6Dv2, FACT-8D, and QLU-C10D in Gastrointestinal Cancers
Valuation of Child-Health-Related Quality of Life by Child Age and Problem Duration Using a Novel Method
Exploratory Economic Evaluation of a Genome Precision Report in Kidney and Liver Transplantation Care
Modeling Systemic Lupus Erythematosus Treatment Cost-Effectiveness Based on a Novel Lupus Low Disease Activity State Treat-to-Target Approach
Impact of Preventive Treatment on Healthcare Use: A Modeling Study of Statin Treatment
Impact of Drug Shortages on Medicare Part D Prescription Drugs Inflation Rebates
Relationships Between Clinician-Confirmed Symptomatic Progression and Change in Patient-Reported Outcomes in Non-Small-Cell Lung Cancer
Systematic Review of Health Economic Evaluations of Oral Nutritional Supplement Interventions in Older Adults: An ISPOR Special Interest Group Report
Swimming in the Sea of Real-World Evidence Guidance: Why More Guidance Will Not Help Researchers Swim
Digital Integration or Physical Premium? A Review of Caregiver Preferences in Early Neurodevelopmental Screening
Short Bowel Syndrome With Intestinal Failure: Healthcare Resource Utilization and Cost of Care in a Large US Claims Database
Swimming in the Sea of Real-World Evidence Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim
Beyond Point-in-Time Appraisal: Connecting DEEM-Q to Lifecycle-Responsive Methodological Quality
Beyond the Checklist: Lifecycle Decision Relevance in Medical Device Economic Evaluation
Clinical and Regulatory Factors Associated with Pivotal Development Duration in FDA Oncology Accelerated Approvals
Cost-Utility of Improving Access to Psychological Therapies compared with usual care in Norway: A Registry-Linked Randomised Trial
Responsiveness, Test-Retest Reliability, and Minimal Important Change of QLU-C10D, PROPr, and EQ-5D-5L in Cancer Patients
Health Economic Evaluations in Immunotherapy and Biologic Treatments for Peanut Allergy: A Systematic Review
Assessment of Real-World Data Elements Describing Social Determinants of Health in Outcomes Research in the United States: An ISPOR Special Interest Group Report
Author Reply
Jahrgänge
2026 · 2832025 · 4.7652024 · 4.9902023 · 4.7092022 · 5.3412021 · 1.3232020 · 3.6552019 · 4.2962018 · 4.8082017 · 2.9772016 · 4.8362015 · 4.6892014 · 4.3302013 · 3.8272012 · 3.5522011 · 3.0042010 · 2.7972009 · 2.6642008 · 2.0982007 · 1.4932006 · 1.2332005 · 1.3352004 · 1.0992003 · 1.0732002 · 7802001 · 7292000 · 5371999 · 5831998 · 210
EUVIMED